Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-19
Closed -$462K 913
2021
Q1
$462K Buy
19
+7
+58% +$195K ﹤0.01% 500
2020
Q4
$259K Buy
+12
New +$288K ﹤0.01% 802
2019
Q3
Sell
-6
Closed -$323K 941
2019
Q2
$323K Sell
6
-10
-63% -$686K ﹤0.01% 832
2019
Q1
$1.32M Buy
16
+1
+7% +$69.2K 0.01% 272
2018
Q4
$1.07M Buy
15
+4
+36% +$355K 0.01% 295
2018
Q3
$1.41M Buy
11
+2
+22% +$236K 0.01% 302
2018
Q2
$879K Hold
9
0.01% 361
2018
Q1
$809K Buy
9
+2
+29% +$190K 0.01% 356
2017
Q4
$357K Buy
+7
New +$438K ﹤0.01% 708

Other funds holding NCNA

ALPS Advisors's NCNA Position: Q2 2021 in Review

ALPS Advisors sold out of NuCana (NCNA) in Q2 2021, closing a stake of 19 shares — an estimated $462K sold.

ALPS Advisors first reported a position in NCNA in Q4 2017 and held it in 9 quarters. The position peaked at $1.41M in Q3 2018. 27 funds tracked by Wall St. Rank hold NCNA as of Q2 2021.

  • ALPS Advisors reported no remaining NuCana position as of Q2 2021 after selling out during the quarter.
  • ALPS Advisors sold 19 NuCana shares in Q2 2021, an estimated $462K.
  • ALPS Advisors first reported a position in NuCana in Q4 2017 and held it in 9 quarters.
  • ALPS Advisors's NuCana position peaked at $1.41M in Q3 2018.
  • 27 funds tracked by Wall St. Rank held NuCana as of Q2 2021.

Based on ALPS Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.